Clene Granted To Meet In-Person With FDA To Discuss CNM-Au8 Biomarker And Related Clinical And Survival Data
Portfolio Pulse from Benzinga Newsdesk
Clene Inc. has been granted an in-person meeting with the FDA, which could be significant for the company's future developments and regulatory approvals.
September 16, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clene Inc. has been granted an in-person meeting with the FDA, which could be significant for the company's future developments and regulatory approvals.
The in-person meeting with the FDA suggests potential progress in Clene's regulatory pathway, which could lead to future product approvals or advancements. This is likely to be viewed positively by investors, as it indicates a step forward in the company's development process.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100